Name | 2,4-Dioxo-N-[4-(3-pyridinyloxy)phenyl]-1,2,3,4-tetrahydro-6-quinazolinesulfonamide |
---|---|
Synonyms |
2,4-Dioxo-N-[4-(3-pyridinyloxy)phenyl]-1,2,3,4-tetrahydro-6-quinazolinesulfonamide
6-Quinazolinesulfonamide, 1,2,3,4-tetrahydro-2,4-dioxo-N-[4-(3-pyridinyloxy)phenyl]- MFCD11667663 |
Description | SIRT2/6-IN-1 (Compound 5) is a SIRT6/SIRT2 inhibitor, with IC50s of 106 μM and 114 μM. SIRT2/6-IN-1 increases H3K9 acetylation, increases glucose uptake and reduces TNF-α secretion in cells[1]. |
---|---|
Related Catalog | |
Target |
106 μM and 114 μM (SIRT6/SIRT2)[1] |
References |
Density | 1.5±0.1 g/cm3 |
---|---|
Molecular Formula | C19H14N4O5S |
Molecular Weight | 410.40 |
Exact Mass | 410.068481 |
LogP | 1.88 |
Index of Refraction | 1.674 |